Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer Chemotherapy

Journal of Medicinal Chemistry
Reshma Rani, Vinit Kumar

Abstract

Human lactate dehydrogenase (hLDH5), a glycolytic enzyme responsible for the conversion of pyruvate to lactate coupled with oxidation of NADH to NAD(+), plays a crucial role in the promotion of glycolysis in invasive tumor cells. Recently, hLDH5 has been considered a vital therapeutic target for invasive cancers. Selective inhibition of hLDH5 using small molecules holds potential prospects for the treatment of cancer and associated diseases. Consequently, significant progress has been made in the discovery of selective small-molecule hLDH5 inhibitors displaying remarkable inhibitory potencies. The purpose of this review is to discuss briefly the roles of hLDH isoforms and to compile small hLDH5 inhibitors into groups based on their chemical classes and pharmacological applications.

References

Mar 31, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·T KannoK Fukutake
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·H ShimC V Dang
Mar 7, 2000·Current Medicinal Chemistry·D L Vander JagtR E Royer
May 30, 2001·Biochemical Pharmacology·Y YuD L Vander Jagt
Feb 24, 1956·Science·O WARBURG
Sep 1, 2005·Clinical & Experimental Metastasis·Michael I KoukourakisEfthimios Sivridis
Feb 24, 2007·Journal of Combinatorial Chemistry·Seoung-ryoung ChoiMitchell A Avery
Feb 15, 1963·Science·A Blanco, W H Zinkham
Jun 10, 2008·Cancer Cell·Guido Kroemer, Jacques Pouyssegur
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Jan 22, 2010·Current Medicinal Chemistry·C GranchiF Minutolo
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Anne LeChi V Dang
Aug 3, 2010·Chemical Communications : Chem Comm·Adam D MoorhouseJohn E Moses
Apr 22, 2011·Nature Reviews. Cancer·Willem H KoppenolChi V Dang
Sep 17, 2011·Nature Reviews. Drug Discovery·Dario Neri, Claudiu T Supuran
Sep 29, 2011·European Journal of Medicinal Chemistry·Carlotta GranchiFilippo Minutolo
Nov 5, 2011·ChemMedChem·Marcella ManerbaMaurizio Recanatini
Nov 8, 2011·Bioorganic & Medicinal Chemistry Letters·Carlotta GranchiFilippo Minutolo
Mar 16, 2012·Journal of Medicinal Chemistry·Richard A WardKevin Hudson
Mar 24, 2012·Cancer Cell·Patrick S Ward, Craig B Thompson
Sep 8, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·F FarabegoliG Di Stefano
Jan 11, 2013·Journal of Medicinal Chemistry·Anna KohlmannDavid C Dalgarno
May 1, 2013·Bioorganic & Medicinal Chemistry Letters·Peter S DragovichXuying Zhang
Sep 10, 2013·Bioorganic & Medicinal Chemistry Letters·Benjamin P FauberQin Yue
Nov 1, 2013·Chembiochem : a European Journal of Chemical Biology·Emilia C CalvaresiPaul J Hergenrother
Nov 2, 2013·Future Medicinal Chemistry·Carlotta GranchiFilippo Minutolo
Mar 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jiujie CuiKeping Xie
Mar 19, 2014·Future Medicinal Chemistry·Luigi FiumeGiuseppina Di Stefano

❮ Previous
Next ❯

Citations

Apr 8, 2016·Future Medicinal Chemistry·Giuseppina Di StefanoLuigi Fiume
Nov 3, 2016·Nature Reviews. Clinical Oncology·Ubaldo E Martinez-OutschoornMichael P Lisanti
Oct 25, 2016·ACS Medicinal Chemistry Letters·Hans E PurkeyAihe Zhou
Jan 25, 2017·Journal of Enzyme Inhibition and Medicinal Chemistry·Peifeng TangShijie Liu
Dec 5, 2017·Journal of Enzyme Inhibition and Medicinal Chemistry·Abdul-Malek S AltamimiRaivis Žalubovskis
Aug 2, 2018·Organic & Biomolecular Chemistry·Gabriella IeronimoAndrea Penoni
Jan 19, 2019·Archives of Pharmacal Research·Soo-Youl Kim
Jul 3, 2019·The Journal of Clinical Investigation·Yihai Cao
Oct 4, 2017·Theoretical Biology & Medical Modelling·Youcef Derbal
Jan 15, 2020·Prostate Cancer and Prostatic Diseases·Salma MeziouFrédéric Pouliot
Dec 29, 2019·International Journal of Molecular Sciences·Cristian O SalasChristian Espinosa-Bustos
Jun 27, 2019·Organic & Biomolecular Chemistry·Gaurav R GuptaAnant R Kapdi
Dec 11, 2020·Cancer Control : Journal of the Moffitt Cancer Center·Erliang GuoSusheng Miao
Feb 23, 2020·Seminars in Cancer Biology·Sajad FakhriAnupam Bishayee
Jan 31, 2021·Journal of Personalized Medicine·Maria Dolores Moya-GarzonMonica Diaz-Gavilan
Feb 7, 2021·Drug Discovery Today·Léopold ThabaultRaphaël Frédérick
Apr 7, 2020·Journal of Medicinal Chemistry·Léopold ThabaultRaphaël Frédérick
Feb 20, 2021·The Journal of Biological Chemistry·Léopold ThabaultRaphaël Frédérick
Mar 26, 2021·Journal of Medicinal Chemistry·Ferran Nadal-BufiSónia Troeira Henriques
Aug 21, 2020·EBioMedicine·Sonia MissiroliCarlotta Giorgi
Mar 16, 2019·Biochemical and Biophysical Research Communications·Mingyu KangDo-Yeon Kim
Apr 4, 2021·Cells·Edward V Prochownik, Huabo Wang
Apr 23, 2021·Analytical Methods : Advancing Methods and Applications·Yi Chen
May 25, 2021·Trends in Endocrinology and Metabolism : TEM·John Henderson, Steven O'Reilly
Jun 3, 2021·International Journal of Molecular Sciences·Jung Ho HanKi-Tae Ha
Jun 30, 2021·Clinical and Translational Medicine·Chien-Shan ChengYibin Feng
Mar 30, 2018·The Journal of Physical Chemistry. B·Juan M Hernández-Meza, José G Sampedro
Sep 10, 2020·Journal of Medicinal Chemistry·Ganesha RaiDavid J Maloney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.